Management of Perioperative Anemia With Iron Carboxymaltose in Jehovah's Witnesses Undergoing Cytoreductive Surgery for Cancer

Key Points

• Management of perioperative anemia significantly improved with iron carboxymaltose in Jehovah's Witnesses undergoing cytoreductive surgery, indicated by increased hemoglobin levels.
• An increase of hemoglobin levels of approximately 2 g/dL was observed following treatment with iron carboxymaltose over the perioperative period.
• The approach included identifying and treating anemia with iron carboxymaltose in a clinical observational analysis of surgical patients.
• These findings highlight the potential for effective anemia management in a unique patient population, paving the way for better surgical outcomes.